SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-046338
Filing Date
2020-10-14
Accepted
2020-10-14 06:01:58
Documents
8
Period of Report
2020-10-14

Document Format Files

Seq Description Document Type Size
1 6-K FOR TLC-19 PATIENT tlc-6k_20201031.htm 6-K 20047
2 EX-99.1 tlc-ex991_6.htm EX-99.1 12352
3 GRAPHIC gp0k4ooesbss000002.jpg GRAPHIC 76979
4 GRAPHIC gp0k4ooesbss000003.jpg GRAPHIC 2080
5 GRAPHIC gp0k4ooesbss000005.jpg GRAPHIC 2080
6 GRAPHIC gp0k4ooesbss000001.jpg GRAPHIC 2080
7 GRAPHIC gp0k4ooesbss000004.jpg GRAPHIC 76979
8 GRAPHIC gp0k4ooesbss000006.jpg GRAPHIC 76979
  Complete submission text file 0001564590-20-046338.txt   360727
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 201238165
SIC: 2834 Pharmaceutical Preparations